Literature DB >> 1582121

Effects of sodium naproxen on differentiated human chondrocytes cultivated in clusters.

C Bassleer1, Y Henrotin, P Franchimont.   

Abstract

The effects of different pharmacological concentrations of the non-steroidal anti-inflammatory drug (NSAID) sodium naproxen (NAP) were tested on several metabolic functions of differentiated human chondrocytes cultivated in clusters and compared with the action of acetylsalicylic acid (ASA). DNA synthesis was significantly inhibited by ASA but not by NAP. Proteoglycan production was also markedly decreased by ASA, while synthesis of type II collagen was not modified. By contrast, NAP did not affect these chondroformative processes. Both NSAIDs were potent inhibitors of prostaglandin E2 production. These results indicate that in terms of the parameters tested NAP does not lead to deleterious effects on human articular chondrocytes cultured in vitro.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1582121     DOI: 10.1007/bf02207086

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  38 in total

1.  In vitro assays of chondrocyte functions: the influence of drugs and hormones.

Authors:  C Bassleer; Y Henrotin; P Franchimont
Journal:  Scand J Rheumatol Suppl       Date:  1990

Review 2.  Laboratory evaluation of antiarthritic drugs as potential chondroprotective agents.

Authors:  D Burkhardt; P Ghosh
Journal:  Semin Arthritis Rheum       Date:  1987-11       Impact factor: 5.532

Review 3.  Nonprescription analgesics.

Authors:  G W Hanks
Journal:  Clin Ther       Date:  1983       Impact factor: 3.393

4.  Isolation and characterization of proteoglycans from the swarm rat chondrosarcoma.

Authors:  T R Oegema; V C Hascall; D D Dziewiatkowski
Journal:  J Biol Chem       Date:  1975-08-10       Impact factor: 5.157

5.  Effect of salicylate on proteoglycan metabolism in normal canine articular cartilage in vitro.

Authors:  M J Palmoski; K D Brandt
Journal:  Arthritis Rheum       Date:  1979-07

6.  Human chondrocytes in tridimensional culture.

Authors:  C Bassleer; P Gysen; J M Foidart; R Bassleer; P Franchimont
Journal:  In Vitro Cell Dev Biol       Date:  1986-03

7.  Effects of human and salmon calcitonin on human articular chondrocytes cultivated in clusters.

Authors:  P Franchimont; C Bassleer; Y Henrotin; P Gysen; R Bassleer
Journal:  J Clin Endocrinol Metab       Date:  1989-08       Impact factor: 5.958

8.  Anti-inflammatory drugs, prostanoid and proteoglycan production by cultured bovine articular chondrocytes.

Authors:  D Mitrovic; E McCall; P Front; F Aprile; N Darmon; F Dray
Journal:  Prostaglandins       Date:  1984-09

9.  Effects of some nonsteroidal antiinflammatory drugs on proteoglycan metabolism and organization in canine articular cartilage.

Authors:  M J Palmoski; K D Brandt
Journal:  Arthritis Rheum       Date:  1980-09

10.  Synthesis of cartilage matrix by mammalian chondrocytes in vitro. I. Isolation, culture characteristics, and morphology.

Authors:  K E Kuettner; B U Pauli; G Gall; V A Memoli; R K Schenk
Journal:  J Cell Biol       Date:  1982-06       Impact factor: 10.539

View more
  3 in total

1.  High density micromass cultures of a human chondrocyte cell line: a reliable assay system to reveal the modulatory functions of pharmacological agents.

Authors:  K V Greco; A J Iqbal; L Rattazzi; G Nalesso; N Moradi-Bidhendi; A R Moore; M B Goldring; F Dell'Accio; M Perretti
Journal:  Biochem Pharmacol       Date:  2011-09-16       Impact factor: 5.858

2.  An Overview Of The Physiology And Pharmacology Of Aspirin And Nonsteroidal Anti-inflammatory Drugs.

Authors:  M C Koester
Journal:  J Athl Train       Date:  1993       Impact factor: 2.860

3.  NSAIDS inhibit in vitro MSC chondrogenesis but not osteogenesis: implications for mechanism of bone formation inhibition in man.

Authors:  Ippokratis Pountos; Peter V Giannoudis; Elena Jones; Anne English; Sarah Churchman; Sarah Field; Frederique Ponchel; Howard Bird; Paul Emery; Dennis McGonagle
Journal:  J Cell Mol Med       Date:  2011-03       Impact factor: 5.310

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.